[The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells]
Shuhong Ming1, Jing Gao, Tieying Sun
1Department of Respiratory Medicine, Beijing Hospital Ministry of Health, Beijing 100730, China. qzf301@sohu.com
Background And Objective:
The expression of TSLC1 is downregulated or abrogated in many kinds of tumors, and its downregulation is highly associated with DNA hypermethlyation. The aim of this study is to explore the relationship between TSLC1 silencing and DNA methylation of its promoter region in lung cancer cells.
Methods:
We detected the expression pattern of TSLC1 in human normal lung tissue and three lung cancer cell lines (A549, NCI-H446 and Calu-3) by semi-quantitative RT-PCR and Real-time PCR. Then we detected the status of DNA methylation in TSLC1 promoter region with bisulfite sequencing in above normal lung tissue and lung cancer cell lines. After treatment of above cell lines with the inhibitor of DNA methyltransferase 5-Aza-2-deoxycytidine (5-Aza-dC), we detected the expression change of TSLC1 by Real-time PCR before and after the treatment of 5-Aza-dC.
Results:
There was no methylation in TSLC1 promoter region in normal lung tissue and A549 cell line in which TSLC1 expressed; while there was DNA hypermethylation in TSLC1 promoter region in NCI-H446 and Calu-3 cell lines in which TSLC1 was abrogated, also the expression of TSLC1 in NCI-H446 and Calu-3 cell lines could be restored after treatment of 5-Aza-dC.
Conclusion:
The silencing of TSLC1 in lung cancer cells is due to the hypermethylation of its promoter region.
Insights
Tumor suppressor TSLC1 gene silencing in lung cancer is linked to DNA hypermethylation of its promoter. Restoring TSLC1 expression is possible by inhibiting DNA methyltransferase.
Area of Science:
- Molecular oncology
- Epigenetics
- Cancer biology
Background:
- TSLC1 gene expression is frequently downregulated or lost in various tumors.
- TSLC1 downregulation correlates strongly with DNA hypermethylation.
- Understanding TSLC1 promoter methylation in lung cancer is crucial.
Purpose of the Study:
- To investigate the association between TSLC1 gene silencing and DNA methylation of its promoter region in lung cancer cells.
- To explore the potential for reversing TSLC1 silencing through epigenetic modification.
Main Methods:
- TSLC1 expression analysis in normal lung tissue and lung cancer cell lines (A549, NCI-H446, Calu-3) using RT-PCR.
- DNA methylation status of the TSLC1 promoter assessed via bisulfite sequencing.
- TSLC1 expression changes evaluated after treatment with 5-Aza-2-deoxycytidine (5-Aza-dC), a DNA methyltransferase inhibitor.
Main Results:
- No methylation observed in the TSLC1 promoter of normal lung tissue and A549 cells (where TSLC1 expressed).
- DNA hypermethylation detected in the TSLC1 promoter of NCI-H446 and Calu-3 cells (where TSLC1 was abrogated).
- TSLC1 expression was restored in NCI-H446 and Calu-3 cells following 5-Aza-dC treatment.
Conclusions:
- TSLC1 gene silencing in lung cancer is attributed to promoter hypermethylation.
- Epigenetic modification via DNA methyltransferase inhibition can reactivate silenced TSLC1.
- TSLC1 promoter methylation serves as a potential biomarker and therapeutic target in lung cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs


